Adam joined the UMBC Career Center in 2023. His 15+ years of experience spans for-profit, nonprofit and academia. He is an AmeriCorps alum and previously guided the undergraduate Internship Program in the Department of Human Development & Family Sciences at the University of Delaware.
UMB and UMBC to Launch New Baltimore Accelerator with Landmark NIH Grant
Join us for our next Maryland BioNetworking Summit, sponsored and organized by UMBC, the Institute for Bioscience and Biotechnology Research (a joint partnership between the University of Maryland and NIST), [….]
UMBC-Shady Grove’s Professional Programs offer pathways to a graduate certificate or master’s degree. Our upcoming virtual Q&A will include an overview from a faculty member in the biotechnology program, followed [….]
Prospective biotechnology graduate students are invited to engage in an evening of getting to know and connecting in-person with our UMBC-Shady Grove Professional Programs community. Join us for an overview [….]
Follow in the paw prints of a Retriever and find out what it’s really like to be an undergraduate Translational Life Science Technology (TLST) student at UMBC-Shady Grove at Retriever [….]
Join us virtually on September 26 at 12 p.m. ET to learn more about the various types of cell and gene therapies available on the market and good manufacturing practice [….]
UMBC professor hopes his new NIH-funded research can speed up the drug approval process Email Facebook LinkedIn Twitter Share article
Chengpeng Chen hopes that his research at UMBC can create a more accurate model of how human organs work, making it easier for drug companies in Baltimore and beyond to earn FDA approval.
Courtesy of UMBC
By Matt Hooke – Reporter
October 10, 2022, 07:32am EDT
A University of Maryland, Baltimore County professor hopes to rapidly speed up the drug approval process, making it easier for drugs to get to market and help patients.
In August, Chengpeng Chen earned a five-year, $1.7 million grant from the National Institutes of Health (NIH) to create a new way to model how drugs will impact human organs, starting with the liver. The device would shorten the time it takes to get U.S. Food and Drug Administration approval by providing a more accurate view of how drugs impact the human body than current testing methods. Baltimore is a hub for medical research, with several area pharmaceutical companies, such as MIRA1a Therapeutics and Alphyn Biologics earning substantial funding rounds. A faster way to get through the FDA approval process could be a boon to the…
The Maryland Stem Cell Research Commission announced it will grant $4,165,325 in award funding to innovative research that will strengthen and advance stem cell treatments and technologies in Maryland.
UMBC will expand its work boosting diversity in academia from Maryland to the national level through a new NSF INCLUDES Alliance: Re-Imagining STEM Equity Utilizing Postdoc Pathways (RISE UPP). The RISE UPP Alliance, anticipated to officially launch in fall 2022, is modeled after the AGEP PROMISE Academy, a high-impact initiative co-led by UMBC that supports faculty diversification in the biomedical sciences across University System of Maryland (USM) institutions.
The UMBC-led RISE UPP Alliance will assist the University of Texas System, Texas A&M University System, and University of North Carolina System in creating programs similar to the AGEP PROMISE Academy, but tailored to meet the needs of their specific institutions and systems. The AGEP PROMISE Academy focuses on recruiting diverse Ph.D. recipients and helping them develop their careers from the postdoc to tenure-track faculty stage. UMBC has received a $10 million grant from the National Science Foundation (NSF) to replicate this national model.
